Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England - 08/04/22

Andrew M. Borman ^{a, b,} 1

  These authors contributed equally to this work.

, ^⁎ , Holly Fountain ^c, 1

  These authors contributed equally to this work.

, Rebecca Guy ^c, Ella Casale ^c, Sarah M Gerver ^c, Suzanne Elgohari ^d, Colin S Brown ^c, Susan Hopkins ^c, Victoria J Chalker ^e, Elizabeth M. Johnson ^{a, b}

^a UK Health Security Agency, Reference Services Division, UK National Mycology Reference Laboratory, Science Quarter, Southmead Hospital, Bristol BS10 5NB, United Kingdom 

^b Medical Research Council Centre for Medical Mycology (MRC CMM), University of Exeter, Exeter EX4 4QD, United Kingdom 

^c HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency. Colindale, London NW9 5HT, United Kingdom 

^d Immunisation and Vaccine Preventable Diseases, UK Health Security Agency. Colindale. London NW9 5HT, United Kingdom 

^e Reference Services Division, Bacterial Reference Department, National Infections Service, UK Health Security Agency, Colindale. London NW9 5HT, United Kingdom 

^⁎Corresponding author at: UK Health Security Agency, Reference Services Division, UK National Mycology Reference Laboratory, Science Quarter, Southmead Hospital, Bristol BS10 5NB, United Kingdom.UK Health Security Agency, Reference Services DivisionUK National Mycology Reference LaboratoryScience Quarter, Southmead HospitalBristolBS10 5NBUnited Kingdom